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ABSTRACT
Objective: Overuse of short-acting bronchodilators is
internationally recognised as a marker of poor asthma
control, high healthcare use and increased risk of
asthma death. Young adults with asthma commonly
overuse short-acting bronchodilators. We sought to
determine the reasons for overuse of bronchodilator
inhalers in a sample of young adults with asthma.
Design: Qualitative study using a purposive extreme
case sample.
Setting: A large urban UK general practice.
Participants: Twenty-one adults with moderate
asthma, aged 20–32 years. Twelve were high users of
short-acting bronchodilators, nine were low users.
Results: Asthma had a major impact on respondents’
lives, disrupting their childhood, family life and career
opportunities. High users of short-acting
bronchodilators had adapted poorly to having asthma
and expressed anger at the restrictions they
experienced. Overuse made sense to them: short-
acting bronchodilators were a rapid, effective, cheap
‘quick-fix’ for asthma symptoms. High users had
poorer control of asthma and held explanatory models
of asthma which emphasised short-term relief via
bronchodilation over prevention. Both high and low
users held strong views about having to pay for
asthma medication, with costs cited as a reason for
not purchasing anti-inflammatory inhalers.
Conclusions: Young adults who were high users of
short-acting bronchodilators had adapted poorly to
having asthma and had poor asthma control. They gave
coherent reasons for overuse. Strategies that might
address high bronchodilator use in young adults
include improving education to help young people
accept and adapt to their illness, reducing
stigmatisation and providing free asthma medication to
encourage the use of anti-inflammatory inhalers.
INTRODUCTION
In total, 300 million people are estimated
worldwide to suffer from asthma.1 Despite
the availability of effective treatments, poor
asthma control is widespread in Europe, Asia
and North America.2 Frequent use of short-
acting β2 agonist inhalers is internationally
recognised as a marker of poor asthma
control, increased risk of hospital admission
and death from asthma.3–10 The serum salbu-
tamol levels in those dying from asthma are,
on average, more than double those of con-
trols of equivalent asthma severity.11 The
risks of oral corticosteroid course, emergency
room attendance and hospitalisation rise
progressively with increasing numbers of
short-acting bronchodilator inhalers dis-
pensed per year.6 Excess healthcare use,
notably hospitalisation, increases the societal
and healthcare costs of asthma markedly.12
Reduced healthcare costs are associated with
good control of asthma.
A cross-sectional analysis of prescribing data
shows that an overuse of short-acting broncho-
dilators is common in young adults.
ARTICLE SUMMARY
Article focus
▪ Why do young adults with asthma overuse
short-acting bronchodilators?
▪ Overuse of bronchodilators is internationally
recognised as a marker of poor asthma control,
excess healthcare use and asthma death—under-
standing the reasons for overuse is a key step
towards developing interventions to address
inappropriate inhaler use.
Key message
▪ Young adults gave coherent reasons for overuse:
they were an effective, cheap, ‘quick-fix’ solution
for asthma symptoms.
Strengths and limitations of this study
▪ First qualitative study to address this topic.
▪ Elegant, purposive sampling design provides
contrast between high and low users of
bronchodilators.
▪ Respondents recruited from a typical urban UK
primary care practice.
Cole S, Seale C, Griffiths C. BMJ Open 2013;3:e002247. doi:10.1136/bmjopen-2012-002247 1
Open Access Research
Thirty-nine per cent of Danish adults, aged 22–44 years,
from a large regional prescribing database, used broncho-
dilators as monotherapy.8 Within a cohort of nearly 10 000
Canadians with asthma aged 15–34 years, 37% were using
no inhaled corticosteroids, and 7% were using more than
12 canisters of bronchodilators per year.4
Asthma in adolescence, the period between the onset
of puberty and attaining an independent responsible
role in society,13 has received considerable attention,
see, for example, Shah14 and Gabe,15 but little work has
focused on young adulthood.
Despite the repeated documentation of bronchodila-
tor overuse in observational studies across continents
and over several decades,3–10 little is understood about
why people, and young adults in particular, overuse
their bronchodilator inhalers. We therefore sought,
using qualitative methods, to examine the experiences
of young adults who overused short-acting bronchodila-
tor inhalers. We aimed to gain insight into reasons for
their overuse.
METHODS
The study was set in a large urban general practice in
the UK. We used purposive sampling to obtain an
extreme case sample of patients using high and low
amounts of short-acting bronchodilators. We searched
computerised practice medical records to identify young
adults with asthma aged 20–32 years, their prescriptions
for short-acting bronchodilators and other asthma medi-
cation and their clinical and demographic characteris-
tics. We identified patients at step 2 (ie, co-prescribed
inhaled steroids) or above of the British Asthma
Guidelines.10 We defined high users of bronchodilators
as those who had received three or more short-acting
bronchodilators in the last 3 months, and low users as
those prescribed two or less in the last 3 months. We
wrote to potential participants giving details of the study
and inviting them to take part. We aimed to broadly
match the high users and low users as far as possible
with respect to a range of variables including: age,
gender, BTS treatment step, duration of asthma diagno-
sis, smoking status and visits to accident and emergency
departments and hospitalisations for asthma. We
reviewed the sample as the study progressed to monitor
and control the evolving composition of the groups.
Patients who responded to our written invitation to the
study were invited to meet with the researcher (SC) to
obtain full details and to give written informed consent.
The North and Mid Essex Local Research Ethics
Committee approved the study (REC MH428). The
study was funded by the East London and Essex
Network for Research. The sponsor and funder had no
influence on the design, analysis or writing.
Interviews
SC carried out semistructured depth interviews with 21
informants. Eighteen were carried out within the
surgery premises in a small private room and three
within the subjects’ own home for their own conveni-
ence, for reasons of childcare. Interviews lasted for
about an hour and were recorded and then transcribed
verbatim with the respondents’ permission.
We developed a topic guide on the basis of the exist-
ing literature and our experience in qualitative research
in asthma. This was refined during the first few inter-
views and covered areas including:
▸ Early memories of asthma diagnosis and treatment;
▸ Experiences and behaviour during asthma
exacerbations;
▸ Impact of asthma on recreation and choices of
careers;
▸ Explanatory models of asthma;
▸ Attitudes to medication and views on the role and
use of medication, particularly inhaled therapy;
▸ Relationships with health professionals;
▸ Social and family networks;
▸ Trade-offs between the use of medication and
other methods of control;
▸ Emotional responses to asthma.
Field notes were taken, and the researcher recorded
general observations of each respondent’s attitude and
behaviour.
Analysis
We used the Framework approach to analyse data.16 This
involves a series of five key stages: familiarisation, identi-
fying a thematic framework, indexing, charting,
mapping and interpretation. Software for qualitative
data analysis (MAXQDA) was used to assist data hand-
ling. The thematic analysis was developed by two of the
authors (SC and CG) who jointly coded all transcripts
and resolved differences of interpretation as the analysis
progressed. As a validity check, a third author (CS, a
medical sociologist) independently read transcripts and
identified no additional themes. The six themes that
emerged from the data covering all 21 respondents com-
prised: impact of asthma, coping, stigma, explanatory
models, rationalisation of inhaler use and costs. We
created charts for each theme, cross-tabulating coded
text for each against respondents.
RESULTS
Table 1 describes the sample interviewed. All were
between 20 and 32 years of age. Most of the respondents
were leading lives fairly typical of this age group; some
were studying, others were in early careers, or they had
young families or responsibilities for ill parents.
Impact of asthma on respondents’ lives
Asthma had a major impact on the lives of most respon-
dents. They described how asthma had restricted their
childhood and disrupted the course of their lives
(box 1). Examples included having to change schools,
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and altering employment opportunities, sometimes
dashing hopes of a chosen career.
Asthma had implications for the social and personal
lives of these young adults. Stigma was common; respon-
dents described being ‘excluded from team activities,
football and things like that’, and ‘just wanting to be like
the rest and not to have to stop and put this thing in my
mouth’. Asthma was ‘so embarrassing’ and inhalers were
something ‘to hide in a bag’.
These young adults gave candid descriptions of the
restrictions they experienced, including the avoidance of
wearing tight, fashionable clothes that could restrict the
breathing, difficulties when dancing at clubs, the inabil-
ity to stay over at friends’ after a night out because
bronchodilators had been forgotten, and the embarrass-
ment of needing to use a bronchodilator during sexual
intercourse (box 2).
Asthma attacks were frightening, life-threatening
experiences (box 3).
An adverse impact of asthma was more often reported
by high users of short-acting bronchodilators. Anger or
resentment at having asthma was mentioned by 8 of 12
high users, but only 1 (who described ‘irritation’) of 9 low
users. Other frustrations were the failure to find a cure,
and the stigmatisation that they felt (boxes 4 and 5).
By contrast, despite similar experiences of asthma, low
users did not express anger about their illness, describ-
ing it as something that was accepted and part of their
lives (box 6). Sometimes, this normalisation reflected
Box 2 Impact of asthma on respondents’ social and per-
sonal lives
Like wearing tight clothes and stuff. I’ve got some nice, pretty
tops for going out clubbing and stuff and you can’t…I couldn’t
wear tight clothing at all umm and some bras that you wear, you
can’t wear them either because it restrains your chest almost so
you…it tightens up your breathing.
14-6 Low user
When I’m out having a dance, I get tight chested. Its a real pain.
17 High user
I might stop in the middle [of sex] to use the blue one.
27f 10-10 High user
Table 1 Characteristics of informants
Low users of short-acting
bronchodilators
High users of short-acting
bronchodilators
Number interviewed 9 12
Mean age (range) 27.4 years (22–30) 26.3 years (20–32)
Mean age at diagnosis (range) 9.3 years (1–19) 8.3 years (1–26)
Female 4 1
Preventer inhalers (mean/year) 6 4
Number on BTS step 2 : step 3 4:5 3:9
Number on ICS/LABA inhalers 5 9
Oral steroids for asthma ever 3 6
Oral steroids in last year 1 2
A&E attendance for asthma ever 3 5
A&E attendance in last year 0 1
Admission for asthma ever 2 5
Admission in last year 0 0
Current smoker 4 6
Had a self-management plan 6 4
Pays for prescriptions 8 8
BTS, British Thoracic Society; ICS, inhaled corticosteroid; LABA, long acting beta agonist.
Box 1 Impact of asthma on the courses of respondents’
lives
It actually changed my life completely…Because I wanted to be a
marine biologist and I actually wanted to study sharks, a PhD in
sharks, had my name down at University and all the rest of it and
I was diving and I spent many years just having to be a snorkeller
because I couldn’t use the tanks and stuff like that and any asth-
matic who dives now, you cannot take your medication for so
many hours before you dive and umm I couldn’t be in that situ-
ation. If you can’t dive, you can’t do your job and actually,
because it was all I’d ever aspired to.
Interviewer: So what did you do instead?
Patient: Nothing as far as I’m concerned (laughter). I just
became…I did office work and umm that was basically it. I did
computer work and very uneventful but then I’ve got my kids…
30f11-9 High user
I would have gone into the army if I had of not had it. I’d have
loved to have joined the army. Really would have done and
there’s lots of things I’d like to have done. I’d like to have been a
policeman…policewoman I should say. I’m not saying that I may
not have been able to get in, but at the back of my mind I think
it’s not worth it. I’ve got asthma, I can’t.
32f 1-12 High user
My mother stayed with me for a year when I was in Great
Ormond Street and my brother and my father stayed in…I lived in
a place called xxx which is quite a distance from London, so yeah
it did cause a separation in the family. I remember going to them
schools in the hospital.
29m19-9 Low user
Cole S, Seale C, Griffiths C. BMJ Open 2013;3:e002247. doi:10.1136/bmjopen-2012-002247 3
Why do young adults with asthma overuse bronchodilator inhalers?
the influence of other family members with asthma.
Parental attitudes may have been important, with low
users reporting positive attitudes of parents to their
illness, and high users reporting negative responses.
Asthma control, explanatory models and medication use
High users often reported poor control of their asthma
symptoms (box 7). Of the 12 high users, 2 rated their
asthma as mild, 8 as moderate and the remaining 2 as
‘moderate-to-severe’; of the 9 low users, 6 reckoned their
asthma to be mild and 3 to be moderate. Although
respondents from both groups described always having a
bronchodilator with them, high users reported ‘having
them everywhere’ and being ‘panicky’ without one, with
elaborate arrangements for having access to bronchodi-
lators. These included having multiple bronchodilator
inhalers at different sites (handbag, car, house, partner’s
Box 6 Acceptance of asthma by low users
Yeah, yeah I mean asthma’s nothing unusual to me. That’s just
part of life really (laughter) and that’s the sort of thing…as I say
my father’s is worse than mine and my brother’s also asthmatic
but his isn’t as bad as mine so.
29f 21-2 Low user
No, not really, because they (bronchodilators) work so fast and
I think they’re very effective and I’ve always had to take medicine
since I’ve been quite young, fairly young, so I don’t really see it
like that. It’s not worth getting angry over. I’m not really that sort
of constitution if you see what I mean—I’m a bit laid back.
I don’t really get angry to be honest.
6-9 Low user
Not really no, I suppose because I’ve had it so long it’s just
kind of there.
23f 7-3 Low user
It doesn’t now. I’m so used to it now, I don’t even think about
it really
25f 12-7 Low user
My mother’s always....you know she started me off making
sure I was using those at home but it was something that, as I
say, I knew that I could get on and do things providing I took the
medication and if I didn’t take the medication, then I was going to
be sat at home wheezing.
29f 21-7 Low user
Box 4 Anger at having asthma
HIGH USERS:
Very angry because I get much iller than everybody else I know
because of it and, you know, it’s not fair and um…I suppose that
when I was ten I did think…my Mum said ‘oh don’t worry, they’ll
find a cure for it before you [grow up]’. Here we go, is it twenty-
two…yeah twenty-two years later, no not really much closer than
what they were when I first [was diagnosed] I just wish they’d
find a cure…I wish to God that they would.
32f 1-16 High user
Interviewer: Are you frightened by having asthma? Respondent:
I’m angry with having asthma.
27f 9-9 High user
Do you feel angry about having asthma? Yes. I think, why me?
I must admit, yes. I have a 6ft 2 brother who’s in perfect health;
there’s nothing ever been wrong with him and you think, why
me?
29f 5-8 High user
I did go on a sort of like a rebellious point and I didn’t want
my medicine. I moved abroad and said ‘I’ve had enough’ and that
was it, I went away as far as I could.
30f 11-10 High user
LOW USERS
You didn’t get angry about it? No, it’s just one of those things
in life isn’t it?
30f 2-8 Low user
Did you resent it? I don’t think so.
23f 7-9 Low user
It’s not worth getting angry over. I’m not really that sort of
constitution if you see what I mean—I’m a bit laid back. I don’t
really get angry to be honest.
29m 6-9 Low user
Box 5 Restrictions and stigma arising from asthma
You do get penalized for a lot of things I think if you’ve got
asthma. I used to love running, used to love running in the 800
metres and cross-country and all that and, you know, I might
have pursued that a bit further had I thought that I wouldn’t keep
getting jeopardised by having this every so often.
1-12 High user
I’m angry with the way people look at people with asthma
because its still quite a…like I say it’s either people are overly in
your face about it or pretend it doesn’t happen and a lot of
people will say to me ‘oh you can’t do that, you’ve got asthma’
and I think ‘how dare you tell me I can’t do something without
letting me have a go at it first’. I suppose I feel a bit angry with
being dealt with it when what I always wanted to do was farming
and it has restricted me from doing it.
27f 9-9 High user
Well, as a child, it stops you doing quite a lot of things, it
limits you umm maybe sets you apart from everyone else a little
bit actually if you’re quite honest about it (inaudible) as a child
with asthma.
29m 19-2 Low user
Box 3 Respondents’ experiences of asthma attacks
That’s the biggest thing is not to panic but it’s like…I’ve always
described it as it’s like drowning but you’re drowning in air
because you can’t get it. It’s like being six foot underneath the
water and you know air is up there and you can’t get it.
30f 11-12 High user
I was out playing once and I started to get really, really tight
chested umm and it got really bad and I think I started to panic
as well, which made it worse, and it got to the point where I was
really, really struggling for breath umm and I probably…bad thing
to do umm over used my inhaler just to clear it, which it did,
I think it was about ten to fifteen minutes and it was very, very,
very scary.
26m,17-2 High user
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home, holiday luggage), and needing to send an email
around the workplace to gain access to bronchodilators
in an emergency.
High users more often held explanatory models of
asthma where the function of the inhalers was solely to
provide quick relief of symptoms by bronchodilation
(box 8). Only 2 of 12 high users spontaneously cited pre-
vention as a function, compared with 8 of 9 low users.
This was reflected in the primacy of bronchodilator
inhalers for this group—one described this as a process
of ‘becoming completely blue’. These inhalers figured
prominently in their thinking about asthma (box 9);
they were seen as a tool to enable young people to get
on with their busy lives—‘a quick fix…to have a couple
of squirts and get back to what you are doing’. The con-
venience of a single inhaler was reflected in comments
such as ‘When I felt wheezy it [the inhaled steroid]
didn’t stop it, the blue one does. Umm…so why carry
two around when you can make do with one?’ The pref-
erence for short-acting bronchodilator inhalers was
simple: ‘Yep. Quick fix, cheaper’. The primacy of bron-
chodilator inhalers might reflect their prescription as
sole therapy at diagnosis: ‘Because you’re prescribed the
blue one first. I mean I was given the Ventolin and that
was it, sent packing.’
Some high users had insight into their inhaler use:
“and it isn’t until you look back and think ‘Christ, I’m
Box 8 Explanatory models of asthma in high and low
users
HIGH USERS:
It’s something to do with the airways closing up and different
things can trigger it like stress or anything—I just can’t remember
much of what the doc told me, I just got told basically the inha-
lers are there to help you and just use them when you need to
and they basically gave me instruction on how to.
25f 4-1 High user
The inside of your lungs—when you breathe—they close up
so the air can’t…I think the oxygen goes in and then it goes into
your lungs and into your blood and I just think they get…closed
up or blocked up and the inhaler just opens them up. I’m prob-
ably completely wrong …
26f 17-3 High user
Interviewer: What does the brown inhaler do? Respondent: I’m
not too sure to be honest with you umm I’ve often thought that it
actually coated your lungs with something.
26f 17-3 High user
Interviewer: OK, so what do you think the orange inhaler does?
Respondent: Prevents it. Interviewer: How? Respondent: I’ve no
idea.
20f 16-4 High user
I have a red one and a brown one at the moment. They’re long-
lasting ones—I think.
29f 5-4 High user
LOW USERS:
When it’s the first time, I take the Bricanyl inhaler as it sort of
opens the airways. With the Flixotide, it’s just generally used so it
keeps the inflammation in the tubes down.
30f 2-7 Low user
The brown one? Well, it doesn’t open up the—it doesn’t dilate
it in the same way, does it? It works through—a bit like adrenal
hormones by reducing, not... inflammation, is it?
29m 6-3 Low user
Box 9 Primacy of short-acting bronchodilator inhalers for
high users
I think it’s [the blue inhaler] probably for, you know, for young
people, I think what it is is that the purple one is more of a build
up isn’t it really umm and the blue one’s just a quick fix to fix
your lungs or whatever quickly so you can just have a couple of
squirts and get back to what you’re doing as opposed to doing
the purple one and having to wait X amount or do it and get built
up and…even though it’s still running in the background, you
know umm the blue one’s good because you can just have a
couple of squirts and get back to whatever you’re doing.
17-12 High user
I know that I’ve just got to have it [salbutamol] and silly little
things like making sure I’ve got enough in the drawer because if
it runs out then I’ve got to worry about getting another one
because I would not go a day…The blue, yeah the reliever, I just
have…it is quite a thing that I need to think about all the time.
27f 10-6 High user
The blue stops what’s happening, happening straight away,
where the preventative…you sometimes forget, it’s at the back of
your mind and you forget to use it…I think mainly that’s why
people…obviously you need to use the blue, when you get
wheezy you have to use the blue where the brown is not going to
help you when you’re really short of breath. Umm and you could
live by just doing that. You wouldn’t have to have that preventative
if you used your blue when you needed it.
27f 10-9 High user
The purple disk preventer I don’t think about as much because
I know I can survive without it.
27f 10-6 High user
Box 7 Asthma control
The blue one takes a battering, it really does and that’s probably
not the best way of doing things but it’s the only way I think…I
mean…if it’s the only way you can be comfortable, then that’s
what you’ve got to do.
17-10 High user
It was when I sat my GCSEs I really…that’s because I was
incredibly ill, because I think my asthma’s also brought on by
stress as well. I start hyperventilating and things like that, and
that was horrific.
30f11-9 High user
I don’t use the blue inhaler at the moment, no. Well, at the
moment, it feels like I’ve never had asthma—it feels like I haven’t
got it.
29m 19-4 Low user.
Once I got onto the Serevent and Flixotide, then that controlled
it much better, and these days I’d use a Ventolin two, three times
a year probably.
29f 21-2 Low user
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doing it sixty or seventy times a day, God, what the hell
am I up to?’ Umm, that’s when you sort of think…but
like I say when I was at college and I couldn’t afford
both, that’s why I always had the blue one. Umm, I
never thought of buying a brown one in preference to
the blue one…’
Cost of prescriptions for asthma medication
Most respondents expressed irritation at having to pay
for asthma prescriptions. In the UK, medication is free
only for children (aged less than 16 years), the elderly
(over 60 years), the unemployed and certain risk groups
(thyroid disorders and diabetes). Asthma was seen as a
life-threatening condition, and as such should have
medication provided free of cost. Cost was seen as a dis-
incentive to obtaining preventive medication (box 10).
DISCUSSION
Principal findings
Asthma had a major impact on the lives of these young
adults, most of whom were in their third decade. High
users of short-acting bronchodilators described poor
adaptation to their illness. They held explanatory
models of asthma which focused on bronchodilation,
with a minority mentioning prevention as a function of
inhalers, or inflammation as a causal factor. Their pref-
erential use of short-acting bronchodilators made sense
to them: they were rapid, effective and cheap: a ‘quick-
fix’ that enabled them to get on with their busy lives. All
respondents were concerned about the cost of asthma
medication and some were clear that this was a major
disincentive to obtaining prophylactic medication. In
the UK, adults over the age of 16 only receive free
medication if they are unemployed, or in certain risk
groups (eg, diabetes and hypothyroidism).
Strengths and weaknesses
The strengths of our study included a qualitative
approach appropriate to the research question
addressed, with a purposive sampling strategy of subjects
designed to generate two groups of respondents that
were reasonably (but not perfectly) matched across a
range of variables. Interviews generated rich data and
considerable insight into personal and sometimes intim-
ate aspects of respondents’ lived experiences of asthma
and the disruption it caused. A constant comparison
approach allowed us to explore emerging themes as they
arose. Reliability was aided by the full transcription of
interviews, use of qualitative software that enabled track-
ing of the analysis, meetings to discuss and resolve
coding differences, and the use of a structured approach
(the Framework method) to analysis. Validity was sup-
ported by having data independently examined by a
third author (a medical sociologist), who identified no
additional themes. While our sample was relatively small,
we achieved data saturation, the most important deter-
minant of sample size in qualitative work. Our sample
was drawn from a single general practice. While caution
should be exercised in generalising findings from any
qualitative work, the patients in this study are likely to be
typical of any UK urban general practice.
Relevance to other work
To our knowledge, no other qualitative studies have
examined this topic, or specifically this age group with
asthma. While Gabe, studying schoolchildren, found
that asthma sufferers generally adapted well to their
illness,15 our data suggest that a minority of children
with asthma strikingly fail to adapt to their illness as they
reach young adulthood. Asthma caused significant dis-
ruption to their lives and aspirations,17 which was
reflected in the feelings of anger, frustration and stigma-
tisation they expressed. These observations on the
process of adaptation (or lack of it) echo those of
Snadden who, in a sample of seven middle-aged
Canadians with asthma, noted: ‘the path to acceptance
varied, and not everyone was able to complete the
journey’.18 Similarly, Adams, also studying an older age
group with asthma, identified ‘deniers, accepters and
pragmatists’.19 In a cross-sectional study, Diette found
that emotional problems with asthma and the cancelling
of social activities were both significantly more common
in bronchodilator overusers.9
In a qualitative study of people with asthma in
Australia, Goeman et al20 also found that paying for
asthma medication could compromise adherence. For
children in the USA aged over 5 years with asthma, the
more parents had to pay for medication, the less medi-
cation was used and the greater was the likelihood of
hospitalisation.21 Interestingly, qualitative work in older
people with asthma suggests that those in whom asthma
Box 10 Prescription charges a disincentive to use of
preventer inhalers
Quick fix and cost, that was my reasons for becoming completely
blue, and the brown one left aside, and even when I did…if
mother got a prescription for me or something, I don’t think I
hardly used it because I became out of routine with it. Yes I must
admit I just used to get the blue one which I think was perhaps
why I got so dependent on the blue because I couldn’t afford to
get both.
27f 129-140 High user
For the preventatives, yes. Definitely, because I’m lazy and I’m
naughty, I should do but there are times when I sort of ‘I’ve got a
bit in me preventative inhaler left at home, I won’t go and get
them any more.’
29f 8-6 Low user
I mean if you’re paying for a prescription and you know that
you need the blue obviously but not the brown, if you’re short of
cash then obviously you’re going to get what you need umm and
the preventative is going to be pushed to one side.
27f 118-120 High user
You have to come and pay for prescriptions, which I despise
doing.
25f 14-10 Low user
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was diagnosed when treatment options were few can
have a wider range of treatment strategies.22
Clinical relevance
These data suggest that considerable benefit could
accrue from improving the asthma control achieved by
young adults who overuse bronchodilators. A number of
strategies might achieve this.
First, more effective education, especially at the time
of diagnosis, but also at routine review, could focus on
helping young people accept and adapt to their illness
as well as helping them to develop an explanatory
model of asthma that focuses on prevention using anti-
inflammatory medication rather than quick relief via
bronchodilators23 Qualitative studies show that people
with asthma value a preventive approach to care and,
moreover, both seek and benefit from the formation of
a partnership approach with their physician.24 25 There
is currently limited evidence that specifically psycho-
logical interventions can improve symptoms and reduce
hospital admissions for asthma.26 27
Negative images of people with asthma are common.
Reducing stigmatisation might help people with asthma
feel more comfortable about using inhalers in public.
This too could improve adaptation and acceptance.
Finally, strategies that might increase the use of pre-
ventive anti-inflammatory treatment in this age group
include promoting the use of a single anti-
inflammatory/bronchodilator combination inhaler,28
and providing free asthma medication. Further studies
are needed to determine the impact of these strategies
on asthma morbidity.
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